Extra-translational roles of aminoacyl tRNA synthetases in connection to disease

氨酰 tRNA 合成酶与疾病相关的翻译外作用

基本信息

  • 批准号:
    8326643
  • 负责人:
  • 金额:
    $ 35.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-06 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Extra-translational role of aminoacyl-tRNA synthetases in connection to disease Abstract: My goal is to understand the expanded functions of glycyl-tRNA synthetase (GlyRS) and how they connect with Charcot-Marie-Tooth (CMT) diseases. GlyRS is one of 20 members of the aminoacyl-tRNA synthetase (AARS) family that catalyzes aminoacylation of transfer tRNAin the first step of protein synthesis. Dominant mutations of GARS (gene for GlyRS) and YARS (gene for tyrosyl-tRNA synthetase) have been identified in the human population to cause Charcot-Marie-Tooth (CMT) diseases. Also known as hereditary motor and sensory neuropathies, CMT diseases are the most common heritable peripheral neuropathy, occurring with a frequency of approximately 1 in 2500 individuals. The CMT phenotype does not arise from a reduction in the essential aminoacylation function. This observation led to our hypothesis that these two tRNA synthetases have expanded functions (beyond aminoacylation) that are critical to understanding their connection to CMT. The focus of the proposal is on GlyRS. A search for interaction partners of GlyRS identified Daxx, a protein that interacts with the cytoplasmic domain of Fas. Fas is a member of the tumor necrosis factor receptor superfamily, and the Fas-Daxx interaction enhances Fas-mediated apoptosis. Significantly, The Fas-Daxx pathway is implicated in CMT, as well as in many other neurological disorders including Amyotrophic Lateral Sclerosis and Parkinson's disease. These considerations raised the possibility that the interaction between GlyRS and Daxx is relevant to the CMT disease-causing mechanism. Surprisingly, we found that a modified form of GlyRS specifically interacts with Daxx. We have identified the modifier of GlyRS to be a ubiquitin-like protein called NEDD8. NEDDylation is known to regulate the function of its substrates. Interestingly, the residue on NEDD8 for conjugation to substrate is the C-terminal glycine, which is conserved in ubiquitin and in almost all ubiquitin-like proteins. The first reaction in NEDDylation is the adenylation of the C- terminal glycine by condensation with ATP. It is chemically the same reaction as the first step of catalysis by GlyRS in aminoacylation. This consideration led us to propose that GlyRS is involved in the NEDDylation of Daxx which, in turn, regulates Daxx-mediated apoptosis. Indeed, we found that GlyRS-associated Daxx is NEDDylated. Thus, the work proposed here will advance understanding of the extra-translational roles of AARS and their possible connection to human disease. PUBLIC HEALTH RELEVANCE: Narrative This project will aid in understanding how tRNA synthetases function in connection to Charcot-Marie-Tooth disease, which is the most common hereditary neuropathy. The knowledge we gain in this study will also shed light on other neurological diseases such as Amyotrophic Lateral Sclerosis (Lou Gehrig's disease) and Parkinson's disease.
描述(由申请人提供):翻译外作用的氨酰-tRNA合成酶在连接到疾病摘要:我的目标是了解扩展功能的甘氨酰-tRNA合成酶(GlyRS),以及它们如何与腓骨肌萎缩症(CMT)疾病。GlyRS是氨酰-tRNA合成酶(阿尔斯)家族的20个成员之一,其在蛋白质合成的第一步中催化转移tRNA的氨酰化。已在人群中鉴定出加尔斯(GlyRS基因)和YARS(酪氨酰-tRNA合成酶基因)的显性突变导致腓骨肌萎缩症(CMT)。CMT疾病也称为遗传性运动和感觉神经病,是最常见的遗传性周围神经病,发生频率约为1/2500。CMT表型不是由必需的氨酰化功能降低引起的。这一观察结果导致我们假设这两种tRNA合成酶具有扩展的功能(超越氨酰化),这对于理解它们与CMT的联系至关重要。该提案的重点是GlyRS。寻找GlyRS的相互作用伙伴确定了Daxx,一种与Fas胞质结构域相互作用的蛋白质。Fas是肿瘤坏死因子受体超家族成员之一,Fas与Daxx相互作用增强Fas介导的细胞凋亡。值得注意的是,Fas-Daxx通路与CMT以及包括肌萎缩性侧索硬化症和帕金森病在内的许多其他神经系统疾病有关。这些考虑提出了GlyRS和Daxx之间的相互作用与CMT致病机制相关的可能性。令人惊讶的是,我们发现GlyRS的修饰形式与Daxx特异性相互作用。我们已经确定GlyRS的修饰剂是一种名为NEDD 8的泛在蛋白样蛋白。已知NEDD化调节其底物的功能。有趣的是,NEDD 8上用于与底物缀合的残基是C-末端甘氨酸,其在泛素和几乎所有泛素样蛋白中是保守的。NEDD化的第一个反应是C-末端甘氨酸与ATP缩合的腺苷酸化.它在化学上与氨基酰化中GlyRS催化的第一步反应相同。这种考虑使我们提出GlyRS参与Daxx的NEDD化,这反过来又调节Daxx介导的细胞凋亡。事实上,我们发现GlyRS相关的Daxx是NEDDylated的。因此,这里提出的工作将促进理解的翻译外作用的阿尔斯和他们可能的连接到人类疾病。 公共卫生相关性:本项目将有助于了解tRNA合成酶如何与Charcot-Marie-Tooth病(最常见的遗传性神经病)相关。我们在这项研究中获得的知识也将揭示其他神经系统疾病,如肌萎缩性侧索硬化症(卢伽雷病)和帕金森病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiang-Lei Yang其他文献

Xiang-Lei Yang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiang-Lei Yang', 18)}}的其他基金

Develop pan-specific antibody against mutant glycyl-tRNA synthetase for treating CMT2D
开发抗突变甘氨酰-tRNA合成酶的泛特异性抗体来治疗 CMT2D
  • 批准号:
    10544795
  • 财政年份:
    2021
  • 资助金额:
    $ 35.72万
  • 项目类别:
Link extracellular function of tRNA synthetase with pathological mechanism of disease
将tRNA合成酶的细胞外功能与疾病的病理机制联系起来
  • 批准号:
    10630282
  • 财政年份:
    2021
  • 资助金额:
    $ 35.72万
  • 项目类别:
Exploring a new arm of the integrated stress response and its connection to neurodegeneration
探索综合应激反应的新分支及其与神经退行性变的联系
  • 批准号:
    10303995
  • 财政年份:
    2021
  • 资助金额:
    $ 35.72万
  • 项目类别:
Link extracellular function of tRNA synthetase with pathological mechanism of disease
将tRNA合成酶的细胞外功能与疾病的病理机制联系起来
  • 批准号:
    10405421
  • 财政年份:
    2021
  • 资助金额:
    $ 35.72万
  • 项目类别:
Develop pan-specific antibody against mutant glycyl-tRNA synthetase for treating CMT2D
开发抗突变甘氨酰-tRNA合成酶的泛特异性抗体来治疗 CMT2D
  • 批准号:
    10541284
  • 财政年份:
    2021
  • 资助金额:
    $ 35.72万
  • 项目类别:
2015 Translation Machinery in Health & Disease Gordon Research Conference
2015年健康翻译机
  • 批准号:
    8831351
  • 财政年份:
    2015
  • 资助金额:
    $ 35.72万
  • 项目类别:
Elucidating pathological mechanism of DI-CMTC
阐明DI-CMTC的病理机制
  • 批准号:
    8725764
  • 财政年份:
    2013
  • 资助金额:
    $ 35.72万
  • 项目类别:
Elucidating pathological mechanism of DI-CMTC
阐明DI-CMTC的病理机制
  • 批准号:
    8611763
  • 财政年份:
    2013
  • 资助金额:
    $ 35.72万
  • 项目类别:
Extra-translational roles of aminoacyl tRNA synthetases in connection to disease
氨酰 tRNA 合成酶与疾病相关的翻译外作用
  • 批准号:
    8536318
  • 财政年份:
    2010
  • 资助金额:
    $ 35.72万
  • 项目类别:
Extra-translational roles of aminoacyl tRNA synthetases in connection to disease
氨酰 tRNA 合成酶与疾病相关的翻译外作用
  • 批准号:
    9177065
  • 财政年份:
    2010
  • 资助金额:
    $ 35.72万
  • 项目类别:

相似海外基金

Elucidation of aging phenomenom based on the assessment of tRNA aminoacylation.
基于 tRNA 氨酰化评估阐明衰老现象。
  • 批准号:
    22K19414
  • 财政年份:
    2022
  • 资助金额:
    $ 35.72万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Elucidating the Functional Role of Post-translational Aminoacylation in Chromatin Regulation
阐明翻译后氨酰化在染色质调节中的功能作用
  • 批准号:
    10489710
  • 财政年份:
    2022
  • 资助金额:
    $ 35.72万
  • 项目类别:
Mechanism of Chiral-Selective Aminoacylation of a Primordial RNA Minihelix Studied by Quantum Chemical Calculations
通过量子化学计算研究原始 RNA 微螺旋的手性选择性氨酰化机制
  • 批准号:
    20K06592
  • 财政年份:
    2020
  • 资助金额:
    $ 35.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
In vitro evolution of a peptide-ribozyme complex catalyzing aminoacylation
催化氨酰化的肽-核酶复合物的体外进化
  • 批准号:
    19K16200
  • 财政年份:
    2019
  • 资助金额:
    $ 35.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Protein/tRNA and conformational changes involved in the faithful aminoacylation of tRNAs specific for glutamate, glutamine, aspartate and aspargine
谷氨酸、谷氨酰胺、天冬氨酸和天冬酰胺特异性 tRNA 的忠实氨酰化涉及的蛋白质/tRNA 和构象变化
  • 批准号:
    9597-2010
  • 财政年份:
    2014
  • 资助金额:
    $ 35.72万
  • 项目类别:
    Discovery Grants Program - Individual
Biomimetic direct aminoacylation of tRNA
tRNA 的仿生直接氨酰化
  • 批准号:
    425730-2012
  • 财政年份:
    2013
  • 资助金额:
    $ 35.72万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Protein/tRNA and conformational changes involved in the faithful aminoacylation of tRNAs specific for glutamate, glutamine, aspartate and aspargine
谷氨酸、谷氨酰胺、天冬氨酸和天冬酰胺特异性 tRNA 的忠实氨酰化涉及的蛋白质/tRNA 和构象变化
  • 批准号:
    9597-2010
  • 财政年份:
    2013
  • 资助金额:
    $ 35.72万
  • 项目类别:
    Discovery Grants Program - Individual
Protein/tRNA and conformational changes involved in the faithful aminoacylation of tRNAs specific for glutamate, glutamine, aspartate and aspargine
谷氨酸、谷氨酰胺、天冬氨酸和天冬酰胺特异性 tRNA 的忠实氨酰化涉及的蛋白质/tRNA 和构象变化
  • 批准号:
    9597-2010
  • 财政年份:
    2012
  • 资助金额:
    $ 35.72万
  • 项目类别:
    Discovery Grants Program - Individual
Biomimetic direct aminoacylation of tRNA
tRNA 的仿生直接氨酰化
  • 批准号:
    425730-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 35.72万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Protein/tRNA and conformational changes involved in the faithful aminoacylation of tRNAs specific for glutamate, glutamine, aspartate and aspargine
谷氨酸、谷氨酰胺、天冬氨酸和天冬酰胺特异性 tRNA 的忠实氨酰化涉及的蛋白质/tRNA 和构象变化
  • 批准号:
    9597-2010
  • 财政年份:
    2011
  • 资助金额:
    $ 35.72万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了